document.write("
"); document.write("
van der Garde,\ M.*\ ; Thomas,\ M.\ ; Riviere,\ J.*\ ; Metzeler,\ K.H.*\ ; Bassermann,\ F.*\ ; Hecker,\ J.*\ ; Marr,\ C.\ ; Goetze,\ K.*
"); document.write("
Single-cell MultiOmic analysis of CHIP bone marrow stem and progenitor cells provides evidence of early-stage malignant transformation.
"); document.write("
Oncol. Res. Treat. 45, 264-265 (2022)
"); document.write("
"); document.write("
"); document.write("
Zeller,\ T.*\ ; Lutz,\ S.*\ ; Munnich,\ I.A.*\ ; Windisch,\ R.*\ ; Hilger,\ P.*\ ; Herold,\ T.*\ ; Tahiri,\ N.*\ ; Banck,\ J.C.*\ ; Weigert,\ O.*\ ; Moosmann,\ A.\ ; von Bergwelt-Baildon,\ M.*\ ; Bruns,\ H.*\ ; Wichmann,\ C.*\ ; Valerius,\ T.*\ ; Schewe,\ D.M.*\ ; Peipp,\ M.*\ ; Roesner,\ T.*\ ; Humpe,\ A.*\ ; Kellner,\ C.*
"); document.write("
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages.
"); document.write("
Oncol. Res. Treat. 45, 2, 162-162 (2022)
"); document.write("
"); document.write("
"); document.write("
Haffner,\ I.*\ ; Schierle,\ K.*\ ; Maier,\ D.*\ ; Geier,\ B.*\ ; Raimundez,\ E.\ ; Hasenauer,\ J.\ ; Luber,\ B.*\ ; Kretzschmar,\ A.K.*\ ; von Weikersthal,\ L.F.*\ ; Ahlborn,\ M.*\ ; Riera,\ J.*\ ; Rau,\ B.*\ ; Siegler,\ G.*\ ; Fuxius,\ S.*\ ; Decker,\ T.*\ ; Wittekind,\ C.*\ ; Lordick,\ F.*
"); document.write("
Treatment of HER2 positive advanced gastric cancer: Deviations in HER2 results and its impact on survival.
"); document.write("
Oncol. Res. Treat. 43, 65-65 (2020)
"); document.write("
"); document.write("
"); document.write("
Cheney,\ C.P.\ ; Thorand,\ B.\ ; Huth,\ C.\ ; Berger,\ K.*\ ; Peters,\ A.\ ; Seifert-Klauss,\ V.*\ ; Kiechle,\ M.*\ ; Strauch,\ K.\ ; Quante,\ A.S.
"); document.write("
The association between serum 25-Hydroxyvitamin D and cancer risk: Results from the prospective KORA F4 study.
"); document.write("
Oncol. Res. Treat. 41, 117-121 (2018)
"); document.write("
"); document.write("
"); document.write("
Haffner,\ I.*\ ; Luber,\ B.*\ ; Maier,\ D.*\ ; Geier,\ B.*\ ; Raimundez-Alvarez,\ E.\ ; Hasenhauer,\ J.\ ; Kretzschmar,\ A.K.*\ ; von Weikersthal,\ F.L.*\ ; Ahlborn,\ M.*\ ; Knorrenschild,\ R.J.*\ ; Rau,\ B.*\ ; Siegler,\ G.*\ ; Fuxius,\ S.*\ ; Decker,\ T.*\ ; Schierle,\ K.*\ ; Wittekind,\ C.*\ ; Lordick,\ F.*
"); document.write("
Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival.
"); document.write("
Oncol. Res. Treat. 41, 240-240 (2018)
"); document.write("
"); document.write("
"); document.write("
Lordick,\ F.*\ ; Haffner,\ I.*\ ; Luber,\ B.*\ ; Maier,\ D.*\ ; Geier,\ B.*\ ; Raimundez-Alvarez,\ E.\ ; Hasenauer,\ J.\ ; Kretzschmar,\ A.K.*\ ; von Weikersthal,\ L.F.*\ ; Ahlborn,\ M.*\ ; Riera,\ J.*\ ; Rau,\ B.*\ ; Siegler,\ G.*\ ; Fuxius,\ S.*\ ; Decker,\ T.*\ ; Schierle,\ K.*\ ; Wittekind,\ C.*
"); document.write("
High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study.
"); document.write("
Oncol. Res. Treat. 41, 191-191 (2018)
"); document.write("
"); document.write("
"); document.write("
Matek,\ C.\ ; Marr,\ C.\ ; Spiekermann,\ K.*
"); document.write("
Computer-aided morphological classification of blood cells relevant in Acute Myeloid Leukemia.
"); document.write("
Oncol. Res. Treat. 41, 197-197 (2018)
"); document.write("
"); document.write("
"); document.write("
Pfirrmann,\ M.*\ ; Baccarani,\ M.*\ ; Saussele,\ S.*\ ; Faber,\ E.*\ ; Bogdanovic,\ A.*\ ; Clark,\ R.*\ ; Hehlmann,\ R.*\ ; Hoffmann,\ V.
"); document.write("
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for prognosis of probabilities of dying of chronicphase chronic myeloid leukaemia.
"); document.write("
Oncol. Res. Treat. 41, 140-141 (2018)
"); document.write("
"); document.write("
"); document.write("
Schirmer,\ D.*\ ; Storz,\ I.*\ ; Wisskirchen,\ K.\ ; Feederle,\ R.\ ; Schmidt,\ O.*\ ; Abken,\ H.*\ ; Protzer,\ U.*\ ; Burdach,\ S.*\ ; Richter,\ G.*
"); document.write("
GPR64-specific CAR-trnasgenic T cells selectively kill Ewing sarcoma cells.
"); document.write("
Oncol. Res. Treat. 41, 130-130 (2018)
"); document.write("
"); document.write("
"); document.write("
Eichner,\ R.*\ ; Heider,\ M.*\ ; Rudelius,\ M.*\ ; Jacobs,\ L.*\ ; Prehn,\ C.\ ; Lemeer,\ S.*\ ; Peschel,\ C.*\ ; Keller,\ U.*\ ; Kuester,\ B.*\ ; Bassermann,\ F.*
"); document.write("
Immunomodulatory drugs destabilize CD98hc and LAT1 to interfere with amino acid transport and tumor metabolism.
"); document.write("
Oncol. Res. Treat. 40, 82-82 (2017)
"); document.write("
"); document.write("
"); document.write("
Gary,\ R.*\ ; Aigner,\ M.*\ ; Moosmann,\ A.\ ; Moi,\ S.*\ ; Schaffer,\ S.*\ ; Balzer,\ H.J.*\ ; Maas,\ S.*\ ; Strobel,\ J.*\ ; Zimmermann,\ R.*\ ; Zingsem,\ J.*\ ; Kremer,\ A.*\ ; Meintker,\ L.*\ ; Mackensen,\ A.*\ ; Gerbitz,\ A.*
"); document.write("
Adoptive transfer of CMV- and EBV-specific peptide-stimulated T cells after allogeneic stem cell transplantation: First results of a phase I/IIa clinical trial [AIT-MULTIVIR-01].
"); document.write("
Oncol. Res. Treat. 40, 239-239 (2017)
"); document.write("
"); document.write("
"); document.write("
Habringer,\ S.*\ ; Herhaus,\ P.*\ ; Schottelius,\ M.*\ ; Istvanffy,\ R.*\ ; Goetze,\ K.*\ ; Oostendorp,\ R.*\ ; Grigoleit,\ G.U.*\ ; Lapa,\ C.*\ ; Jeremias,\ I.\ ; Schwaiger,\ M.*\ ; Peschel,\ C.*\ ; Wester,\ H.-J.*\ ; Keller,\ U.*
"); document.write("
CXCR4-directed peptide receptor radiotherapy with \177\Lu-Pentixather effectively clears leukemia in patient-derived xenografts.
"); document.write("
Oncol. Res. Treat. 40, 214-214 (2017)
"); document.write("
"); document.write("
"); document.write("
Jacobs,\ L.A.*\ ; Slawska,\ J.*\ ; Hoellein,\ A.*\ ; Prehn,\ C.\ ; Adamski,\ J.\ ; Keller,\ U.*
"); document.write("
A study of Myc-regulated metabolic changes in transformed B cells.
"); document.write("
Oncol. Res. Treat. 40, 218-218 (2017)
"); document.write("
"); document.write("
"); document.write("
Krupka,\ C.\ ; Lindl,\ B.\ ; Piatzer,\ J.\ ; Brauneck,\ F.\ ; Kischel,\ R.*\ ; Kufer,\ P.*\ ; Lichtenegger,\ F.S.\ ; Koehnke,\ T.\ ; Rothe,\ M.\ ; Deiser,\ K.\ ; Augsberger,\ C.\ ; Altmann,\ T.\ ; Spiekermann,\ K.*\ ; Hiddemann,\ W.*\ ; Subklewe,\ M.
"); document.write("
Influence of cytoreductive and immunmodulatory drugs on antibody-based approaches in AML.
"); document.write("
Oncol. Res. Treat. 40, 84-85 (2017)
"); document.write("
"); document.write("
"); document.write("
Lichtenegger,\ F.S.\ ; Deiser,\ K.\ ; Rothe,\ M.\ ; Krupka,\ C.\ ; Schnorfeil,\ F.M.\ ; Augsberger,\ C.\ ; Koehnke,\ T.*\ ; Buecklein,\ V.*\ ; Altmann,\ T.*\ ; Moosmann,\ A.\ ; Brueggemann,\ M.*\ ; Heemskerk,\ M.H.M.*\ ; Wagner,\ B.*\ ; Hiddemann,\ W.*\ ; Bigalke,\ I.*\ ; Kvalheitn,\ G.*\ ; Subklewe,\ M.
"); document.write("
Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: Results of a phase I/II trial and ex vivo enhancement by checkpoint blockade.
"); document.write("
Oncol. Res. Treat. 40, 135-135 (2017)
"); document.write("
"); document.write("
"); document.write("
Richter,\ A.S.*\ ; Roolf,\ C.*\ ; Sender,\ S.*\ ; Sekora,\ A.*\ ; Knbel,\ G.*\ ; Vollmar,\ B.*\ ; Jeremias,\ I.\ ; Escobar,\ M.H.*\ ; Junghanss,\ C.*
"); document.write("
CK2 inhibition reduces cell proliferation in acute B-lymphoblastic leukemia cells in vitro and in vivo.
"); document.write("
Oncol. Res. Treat. 40, 20-20 (2017)
"); document.write("
"); document.write("
"); document.write("
Friemel,\ I.*\ ; Rechsteiner,\ M.P.*\ ; Frick,\ L.*\ ; Boehm,\ F.*\ ; Struckmann,\ K.*\ ; Egger,\ M.*\ ; Moch,\ N.*\ ; Heikenwälder,\ M.\ ; Weber,\ A.*
"); document.write("
Intratumor heterogeneity in hepatocellular carcinoma: Impact on tumor classifications and targeted therapies.
"); document.write("
Oncol. Res. Treat. 39, 81 (2016)
"); document.write("
"); document.write("
"); document.write("
Gross,\ E.*\ ; Brunet,\ T.*\ ; Napieralski,\ R.*\ ; Singer,\ T.*\ ; Aubele,\ M.\ ; Schmitt,\ M.*\ ; Meindl,\ A.*\ ; Lips,\ E.*\ ; Kiechle,\ M.*
"); document.write("
Validation of a BRCAness test to select for targeted therapies in triple-negative breast cancer.
"); document.write("
Oncol. Res. Treat. 39, 54 (2016)
"); document.write("
"); document.write("
"); document.write("
Habringer,\ S.*\ ; Herhaus,\ P.*\ ; Schottelius,\ M.*\ ; Istvanffy,\ R.*\ ; Goetze,\ K.*\ ; Oostendorp,\ R.*\ ; Grigoleit,\ G.U.*\ ; Lapa,\ C.*\ ; Jeremias,\ I.\ ; Schwaiger,\ M.*\ ; Peschel,\ C.*\ ; Wester,\ H.-J.*\ ; Keller,\ U.*
"); document.write("
CXCR4-directed peptide receptor radiotherapy with 177Lu-Pentixather effectively clears leukemia in patient-derived xenografts.
"); document.write("
Oncol. Res. Treat. 39, 214-214 (2016)
"); document.write("
"); document.write("
"); document.write("
Haffner,\ I.*\ ; Luber,\ B.*\ ; Maier,\ D.*\ ; Geier,\ B.*\ ; Theis,\ F.J.\ ; Meyer-Hermann,\ M.*\ ; Walch,\ A.K.\ ; Kretzschmar,\ A.K.*\ ; von Weikersthal,\ L.F.*\ ; Knorrenschild,\ J.R.*\ ; Schierle,\ K.*\ ; Wittekind,\ C.*\ ; Lordick,\ F.*
"); document.write("
Clinical validation of response and resistance factor candidates to targeted therapy in Gastric Cancer (GC).
"); document.write("
Oncol. Res. Treat. 39, 16-17 (2016)
"); document.write("
"); document.write("
"); document.write("
Jacobs,\ L.A.*\ ; Slawska,\ J.*\ ; Hoellein,\ A.*\ ; Prehn,\ C.\ ; Adamski,\ J.\ ; Keller,\ U.*
"); document.write("
A study of Myc-regulated metabolic changes in transformed B cells.
"); document.write("
Oncol. Res. Treat. 39, 218-218 (2016)
"); document.write("
"); document.write("
"); document.write("
Krupka,\ C.\ ; Lindl,\ B.\ ; Platzer,\ J.\ ; Brauneck,\ F.\ ; Kischel,\ R.*\ ; Kufer,\ P.*\ ; Lichtenegger,\ F.S.\ ; Koehnke,\ T.\ ; Rothe,\ M.\ ; Deiser,\ K.\ ; Augsberger,\ C.\ ; Altmann,\ T.\ ; Spiekermann,\ K.*\ ; Hiddemann,\ W.*\ ; Subklewe,\ M.
"); document.write("
Influence of cytoreductive and immunmodulatory drugs on antibody-based approaches in AML.
"); document.write("
Oncol. Res. Treat. 39, 84-85 (2016)
"); document.write("
"); document.write("
"); document.write("
Lichtenedger,\ F.S.\ ; Deiser,\ K.\ ; Rothe,\ M.\ ; Krupka,\ C.\ ; Schnorfeil,\ F.M.\ ; Augsberger,\ C.\ ; Koehnke,\ T.*\ ; Buecklein,\ V.*\ ; Altmann,\ T.*\ ; Moosmann,\ A.\ ; Brueggemann,\ M.*\ ; Heemskerk,\ M.H.M.*\ ; Wagner,\ B.*\ ; Hiddemann,\ W.R.*\ ; Bigalke,\ I.*\ ; Kvalheim,\ G.*\ ; Subklewe,\ M.
"); document.write("
Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: results of a phase I/II trial and ex vivo enhancement by checkpoint blockade.
"); document.write("
Oncol. Res. Treat. 39, 135-135 (2016)
"); document.write("
"); document.write("
"); document.write("
Neff,\ F.*\ ; Kirsch,\ D.G.*\ ; Saur,\ D.*\ ; Schmid,\ R.M.*\ ; Bazhin,\ A.V.*\ ; Heikenwälder,\ M.\ ; Siveke,\ J.T.*
"); document.write("
Targeting notch for myeloid reprogramming in pancreatic cancer.
"); document.write("
Oncol. Res. Treat. 39, 16 (2016)
"); document.write("
"); document.write("
"); document.write("
Trajkovic-Arsic,\ M.*\ ; Kalideris,\ E.*\ ; Sun,\ N.\ ; Feuchtinger,\ A.\ ; Gupta,\ A.*\ ; Aichler,\ M.\ ; Schmid,\ R.M.*\ ; Walch,\ A.K.\ ; Siveke,\ J.T.*
"); document.write("
Identification of metabolic changes in pancreatic ductal adenocarcinoma.
"); document.write("
Oncol. Res. Treat. 39, 76-77 (2016)
"); document.write("
"); document.write("
"); document.write("
Willier,\ S.*\ ; Unland,\ R.*\ ; Janik,\ D.\ ; Neff,\ F.\ ; da Costa,\ O.P.*\ ; Dirksen,\ U.*\ ; Butt,\ E.*\ ; Grunewald,\ T.G.*\ ; Burdach,\ S.*\ ; Richter,\ G.*
"); document.write("
Role of Thyroid Receptor Interacting Protein 6 (TRIP6) in migration and invasion of Ewing\' sarcoma cells.
"); document.write("
Oncol. Res. Treat. 39, 145 (2016)
"); document.write("
"); document.write("
"); document.write("
Bücklein,\ V.L.\ ; Kampmann,\ E.*\ ; Nößner,\ E.\ ; Issels,\ R.D.*\ ; Lindner,\ L.*\ ; Subklewe,\ M.\ ; Knoesel,\ T.*
"); document.write("
Intratumoral immune cell infiltration in patients with high-grade soft-tissue sarcoma is associated with tumor grading.
"); document.write("
Oncol. Res. Treat. 38, 246-247 (2015)
"); document.write("
"); document.write("
"); document.write("
Bücklein,\ V.L.\ ; Jorg,\ T.\ ; Pass,\ D.\ ; Krupka,\ C.\ ; Schlegel,\ P.G.*\ ; Lang,\ P.*\ ; Sen,\ H.H.*\ ; Lindner,\ L.*\ ; Hiddemann,\ W.R.*\ ; Subklewe,\ M.
"); document.write("
Immunotherapeutic strategies for soft-tissue sarcoma: Preclinical results of Natural Killer cell augmentation by ex vivo expansion and use of an anti-GD2 antibody.
"); document.write("
Oncol. Res. Treat. 38, 149-150 (2015)
"); document.write("
"); document.write("
"); document.write("
Freysoldt,\ B.\ ; Schnaiter,\ A.\ ; Zimmermann,\ Y.\ ; Hutter,\ G.\ ; Hiddemann,\ W.\ ; Dreyling,\ M.
"); document.write("
Cotargeting of PIM, PI3K and mTOR in mantle cell lymphoma.
"); document.write("
Oncol. Res. Treat. 38, 63 (2015)
"); document.write("
"); document.write("
"); document.write("
Garz,\ A.-K.*\ ; Weickert,\ M.-T.*\ ; Pagel,\ C.*\ ; Habringer,\ S.*\ ; Vick,\ B.\ ; Jeremias,\ I.\ ; Keller,\ U.*\ ; Oostendorp,\ R.*\ ; Peschel,\ C.*\ ; Goetze,\ K.*
"); document.write("
The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche.
"); document.write("
Oncol. Res. Treat. 38, 214 (2015)
"); document.write("
"); document.write("
"); document.write("
Habringer,\ S.*\ ; Li,\ Z.*\ ; Pietschmann,\ E.*\ ; Slawska,\ J.*\ ; Walch,\ A.K.\ ; Peschel,\ C.*\ ; Keller,\ U.*
"); document.write("
Very early functional \in-vivo\ imaging to predict response to B cell receptor pathway targeting in lymphoma.
"); document.write("
Oncol. Res. Treat. 38, 99 (2015)
"); document.write("
"); document.write("
"); document.write("
Hatzl,\ S.*\ ; Geiger,\ O.*\ ; Kuepper,\ M.K.*\ ; Seime,\ T.*\ ; Nussbaumer,\ E.*\ ; Wieser,\ R.*\ ; Pichler,\ M.*\ ; Scheideler,\ M.\ ; Nowek,\ K.*\ ; Jongen-Lavrencic,\ M.*\ ; Woelfler,\ A.*\ ; Troppmair,\ J.*\ ; Sill,\ H.*\ ; Zebisch,\ A.*
"); document.write("
Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a.
"); document.write("
Oncol. Res. Treat. 38, 99 (2015)
"); document.write("
"); document.write("
"); document.write("
Köhnke,\ T.\ ; Rechkemmer,\ S.*\ ; Bücklein,\ V.L.\ ; Hiddemann,\ W.*\ ; Subklewe,\ M.
"); document.write("
Feasibility of semi-automated MRD analysis by flow cytometry in acute myeloid leukemia.
"); document.write("
Oncol. Res. Treat. 38, 46 (2015)
"); document.write("
"); document.write("
"); document.write("
Krupka,\ C.\ ; Kufer,\ P.*\ ; Kischel,\ R.*\ ; Zugmaier,\ G.*\ ; Köhnke,\ T.\ ; Lichtenegger,\ F.S.\ ; Altmann,\ T.\ ; Spiekermann,\ K.*\ ; Vick,\ B.\ ; Jeremias,\ I.\ ; Hiddemann,\ W.*\ ; Subklewe,\ M.
"); document.write("
Combining immune checkpoint inhibition with the CD33 BiTE (R) antibody construct AMG 330 to enhance T cell mediated lysis of primary AML cells.
"); document.write("
Oncol. Res. Treat. 38, 38 (2015)
"); document.write("
"); document.write("
"); document.write("
Lichtenegger,\ F.S.\ ; Schnorfeil,\ F.M.\ ; Brueggemann,\ M.*\ ; Moosmann,\ A.\ ; Köhnke,\ T.*\ ; Buecklein,\ V.*\ ; Altmann,\ T.*\ ; Wagner,\ B.*\ ; Hiddemann,\ W.*\ ; Bigalke,\ I.*\ ; Kvalheim,\ G.*\ ; Subklewe,\ M.
"); document.write("
Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial.
"); document.write("
Oncol. Res. Treat. 38, 37 (2015)
"); document.write("
"); document.write("
"); document.write("
Zoellner,\ A.-K.*\ ; Ruetgen,\ B.*\ ; Hutter,\ G.\ ; Zimmermann,\ Y.\ ; Mohring,\ M.*\ ; Hiddemann,\ W.\ ; Hirschberger,\ J.*\ ; Dreyling,\ M.
"); document.write("
The B-cell receptor pathway is highly actived in canine DLBCL cell line CLBL-1.
"); document.write("
Oncol. Res. Treat. 38, 65 (2015)
"); document.write("
"); document.write("
"); document.write("
Bruns,\ H.*\ ; Bittenbring,\ J.T.*\ ; Mougiakakos,\ D.*\ ; Fabri,\ M.*\ ; Buettner,\ M.*\ ; Pasemann,\ S.*\ ; Kempkes,\ B.\ ; Mackensen,\ A.*\ ; Gerbitz,\ A.*
"); document.write("
Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high grade B-cell lymphoma.
"); document.write("
Oncol. Res. Treat. 37, 70 (2014)
"); document.write("
"); document.write("
"); document.write("
Harnicek,\ D.\ ; Kampmann,\ E.*\ ; Tanovic,\ A.*\ ; Martins,\ A.S.C.\ ; Guo,\ Y.*\ ; Gallmeier,\ E.*\ ; Kanaar,\ R.*\ ; Lauber,\ K.*\ ; Knoesel,\ T.*\ ; Lindner,\ L.*\ ; Issels,\ R.D.
"); document.write("
Hyperthermia combined with trabectedin prolongs G2 cell cycle arrest and reduces cellular survival in human tumor cells.
"); document.write("
Oncol. Res. Treat. 37, 116 (2014)
"); document.write("
"); document.write("
"); document.write("
Hellmuth,\ J.\ ; Szczepanowski,\ M.*\ ; Staiger,\ A.*\ ; Pastore,\ A.\ ; Hartmann,\ S.*\ ; Tschuri,\ S.\ ; Hansmann,\ M.-L.*\ ; Ott,\ G.*\ ; Rosenwald,\ A.*\ ; Louissaint,\ J.A.*\ ; Kridel,\ R.*\ ; van Hummelen,\ P.*\ ; Ducar,\ M.D.*\ ; Hiddemann,\ W.*\ ; Sehn,\ L.H.*\ ; Moccia,\ A.A.*\ ; Gascoyne,\ R.D.*\ ; Weinstock,\ D.M.*\ ; Klapper,\ W.*\ ; Weigert,\ O.
"); document.write("
Gastrointestinal Follicular Lymphoma (FL) differs from nodal FL by absence of EZH2 mutations.
"); document.write("
Oncol. Res. Treat. 37, 75 (2014)
"); document.write("
"); document.write("
"); document.write("
Jansen,\ L.*\ ; Eberle,\ A.*\ ; Emrich,\ K.*\ ; Gondos,\ A.*\ ; Holleczek,\ B.*\ ; Kajueter,\ H.*\ ; Maier,\ W.\ ; Nennecke,\ A.*\ ; Pritzkuleit,\ R.*\ ; Brenner,\ H.*
"); document.write("
Socio-economic deprivation and cancer survival in Germany.
"); document.write("
Oncol. Res. Treat. 37, 34 (2014)
"); document.write("
"); document.write("
"); document.write("
Kobold,\ S.*\ ; Steffen,\ J.*\ ; Chaloupka,\ M.*\ ; Grassmann,\ S.*\ ; Henkel,\ J.*\ ; Castoldi,\ R.*\ ; Zeng,\ Y.*\ ; Chmielewski,\ M.*\ ; Schmollinger,\ J.C.*\ ; Schnurr,\ M.*\ ; Rothenfusser,\ S.*\ ; Schendel,\ D.J.\ ; Abken,\ H.*\ ; Sustmann,\ C.*\ ; Niederfellner,\ G.*\ ; Klein,\ C.*\ ; Bourquin,\ C.*\ ; Endres,\ S.*
"); document.write("
Bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer.
"); document.write("
Oncol. Res. Treat. 37, 239 (2014)
"); document.write("
"); document.write("
"); document.write("
Lichtenegger,\ F.S.\ ; Schnorfeil,\ F.M.\ ; Emmerig,\ K.\ ; Schlueter,\ M.\ ; Neitz,\ J.S.\ ; Altmann,\ T.*\ ; Draenert,\ R.*\ ; Hiddemann,\ W.*\ ; Subklewe,\ M.
"); document.write("
T cell differentiation but not exhaustion in AML.
"); document.write("
Oncol. Res. Treat. 37, 225 (2014)
"); document.write("
"); document.write("
"); document.write("
Lichtenegger,\ F.S.\ ; Schnorfeil,\ F.M.\ ; Altmann,\ T.*\ ; Köhnke,\ T.*\ ; Buecklein,\ V.*\ ; Geiger,\ C.\ ; Wagner,\ B.*\ ; Henschler,\ R.*\ ; Bigalke,\ I.\ ; Kvalheim,\ G.*\ ; Hiddemann,\ W.*\ ; Schendel,\ D.J.\ ; Subklewe,\ M.*
"); document.write("
Next-generation dendritic cell vaccination as postremission therapy for AML patients with a non-favorable risk profile.
"); document.write("
Oncol. Res. Treat. 37, 310 (2014)
"); document.write("
"); document.write("
"); document.write("
Malkomes,\ P.*\ ; Haetscher,\ N.*\ ; Oellerich,\ T.*\ ; Schroeder,\ T.\ ; Holzer,\ K.*\ ; Serve,\ H.*\ ; Bechstein,\ W.O.*\ ; Rieger,\ M.*
"); document.write("
Characterization of colon cancer stem cells at the single cell level for target identification in diagnosis and therapy.
"); document.write("
Oncol. Res. Treat. 37, 120 (2014)
"); document.write("
"); document.write("
"); document.write("
Neumann,\ M.*\ ; Vosberg,\ S.\ ; Heesch,\ S.*\ ; Schlee,\ C.*\ ; Schwartz,\ S.*\ ; Goekbuget,\ N.*\ ; Hoelzer,\ D.*\ ; Graf,\ A.*\ ; Krebs,\ S.*\ ; Blum,\ H.*\ ; Hecht,\ J.*\ ; Greif,\ P.A.\ ; Baldus,\ C.D.*
"); document.write("
T-ALL is characterized by heterogeneous pattern of gene mutations and their variant allele frequencies.
"); document.write("
Oncol. Res. Treat. 37, 180 (2014)
"); document.write("
"); document.write("
"); document.write("
Peter,\ N.\ ; Zoellner,\ A.-K.*\ ; Zimmermann,\ Y.\ ; Hutter,\ G.\ ; Hiddemann,\ W.\ ; Dreyling,\ M.
"); document.write("
Interaction of anti-CD20 antibodies and inhibitors of the B-cell receptor pathway in diffuse large B-cell lymphoma.
"); document.write("
Oncol. Res. Treat. 37, 72 (2014)
"); document.write("
"); document.write("
"); document.write("
Yabal,\ M.*\ ; Müller,\ N.*\ ; Adler,\ H.\ ; Knies,\ N.*\ ; Gross,\ C.J.*\ ; Damgaard,\ R.B.*\ ; Kanegane,\ H.*\ ; Ringelhan,\ M.\ ; Kaufmann,\ T.*\ ; Heikenwälder,\ M.\ ; Strasser,\ A.*\ ; Gross,\ O.*\ ; Ruland,\ J.*\ ; Peschel,\ C.*\ ; Gyrd-Hansen,\ M.*\ ; Jost,\ P.J.*
"); document.write("
Aberrant TNF signalling in dendritic cells in the absence of XIAP contributes to X-linked lymphoproliferative disease (XLP-2) by exaggerated necroptosis.
"); document.write("
Oncol. Res. Treat. 37, 246 (2014)
"); document.write("
"); document.write("
"); document.write("
Zhao,\ Y.*\ ; Wang,\ Y.*\ ; Zhao,\ L.*\ ; Gros,\ S.*\ ; Mysliwietz,\ J.\ ; Ellwart,\ J.W.\ ; Niess,\ H.*\ ; Betzler,\ C.*\ ; Jauch,\ K.-W.*\ ; Nelson,\ P.*\ ; Bruns,\ C.*
"); document.write("
CXCR4 over-expression is associated with Cisplatin resistance in esophageal carcinoma.
"); document.write("
Oncol. Res. Treat. 37, 99 (2014)
"); document.write("
"); document.write("
"); document.write("
Zoellner,\ A.-K.\ ; Arndt,\ J.\ ; Hutter,\ G.\ ; Zimmermann,\ Y.\ ; Hiddemann,\ W.\ ; Dreyling,\ M.
"); document.write("
Efficacy of PI3K-inhibitors in Mantle Cell Lymphoma (MCL).
"); document.write("
Oncol. Res. Treat. 37, 72 (2014)
"); document.write("
");